HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

682.678

-34.563-4.82%

Number of Gainers:- -

Number of Losers:9

Number of Flat:4

PE:- -

High:693.738

Open:678.885

Low:675.692

Close:717.241

Loading ...

Sihuan Pharmaceutical Unit's Diabetes Drug Gets Registration Approval in China

MT Newswires Live

BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPA

Sihuan Pharma - Dapagliflozin Tablets Developed by Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa

THOMSON REUTERS

BRIEF-China Medical System Announces Proposed Spin-Off And Separate Listing Of Dermavon Holdings

China Medical System Holdings - Proposed Spin-off and Separate Listing of Dermavon Holdings Limited

THOMSON REUTERS

3SBio's Lung Cancer Drug Gets Breakthrough Therapy Designation in China

MT Newswires Live

BRIEF-3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA

3SBio - 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS

BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share

Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share

THOMSON REUTERS

Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm

MT Newswires Live

Corrected-Lai Fung Holdings H1 Turnover HKD 647.8 Million (Corrects Number)

THOMSON REUTERS

Angelalign Technology Inc. (HKG:6699) May Have Run Too Fast Too Soon With Recent 27% Price Plummet

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":682.67786,"timestamp":1745805704839,"preClose":717.24054,"halted":0,"volume":48624739,"delay":0,"changeRate":-0.048188,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-34.562683,"latestTime":"04-28 10:01:44","open":678.8851,"high":693.73816,"low":675.6922,"amount":459511178,"amplitude":0.02516,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1745812800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":1.255448,"peRate":19.315719,"turnoverRate":0.002429,"increases":0,"decrements":9,"flats":4,"marketCap":117724288872,"floatMarketCap":81799878504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":693.73816,"amplitude":0.02516,"preClose":717.24054,"low":675.6922,"pbRate":"1.255448","latestPrice":682.67786,"volume":48624739,"delay":0,"open":678.8851,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":661.02,"twentyDayClose":662.617,"sixtyDayClose":538.937,"secType":"PLATE","market":"HK","turnoverRate":0.002429,"peRate":19.315719,"marketCap":117724288872,"floatMarketCap":81799878504,"timestamp":1745805704839,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":0,"down":9,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529672710","title":"Sihuan Pharmaceutical Unit's Diabetes Drug Gets Registration Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2529672710","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529672710?lang=en_us&edition=fundamental","pubTime":"2025-04-24 17:36","pubTimestamp":1745487415,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration granted drug registration approval for Sihuan Pharmaceutical  subsidiary Huisheng Biopharmaceutical's Dapagliflozin tablets for the treatment of type 2 diabetes in adult patients.The medication also passed China's consistency evaluation of quality and efficacy of generic drugs, according to a Wednesday filing with the Hong Kong Exchange.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1600","BK1191","BK1515","BK1593","00460"],"gpt_icon":0},{"id":"2529631655","title":"BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631655?lang=en_us&edition=fundamental","pubTime":"2025-04-23 23:26","pubTimestamp":1745421990,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPAApril 23 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:DAPAGLIFLOZIN TABLETS DEVELOPED BY HUI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R10YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"2529050052","title":"Sihuan Pharma - Dapagliflozin Tablets Developed by Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2529050052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529050052?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:38","pubTimestamp":1745411923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R10YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1600","BK1191","00460","BK1593"],"gpt_icon":0},{"id":"2529446532","title":"BRIEF-China Medical System Announces Proposed Spin-Off And Separate Listing Of Dermavon Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2529446532","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529446532?lang=en_us&edition=fundamental","pubTime":"2025-04-23 01:08","pubTimestamp":1745341717,"startTime":"0","endTime":"0","summary":"BRIEF-China Medical System Announces Proposed Spin-Off And Separate Listing Of Dermavon HoldingsApril 22  - China Medical System Holdings Ltd 0867.HK:PROPOSED SPIN-OFF AND SEPARATE LISTING OF DERMAVON HOLDINGS LIMITEDSEPARATE LISTING OF DERMAVON HOLDINGS ON MAIN BOARD OF STOCK EXCHANGE OF HONG KONGFurther company coverage: 0867.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R0235:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","LU2488822045.USD","BK1593","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015952.SGD","BK1191","SG9999015986.USD","SG9999004220.SGD","00867"],"gpt_icon":0},{"id":"2529583276","title":"China Medical System Holdings - Proposed Spin-off and Separate Listing of Dermavon Holdings Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2529583276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529583276?lang=en_us&edition=fundamental","pubTime":"2025-04-22 21:32","pubTimestamp":1745328772,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R0235:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BMCWC346.EUR","00867","SG9999015978.USD","SG9999015986.USD","IE00BYV24P56.USD","BK1191","SG9999015952.SGD","LU2488822045.USD","BK1593","SG9999015945.SGD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2528508155","title":"3SBio's Lung Cancer Drug Gets Breakthrough Therapy Designation in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2528508155","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528508155?lang=en_us&edition=fundamental","pubTime":"2025-04-18 12:19","pubTimestamp":1744949994,"startTime":"0","endTime":"0","summary":"3SBio  said its 707 injection was granted a breakthrough therapy designation by China's National Medical Products Administration, according to a late Thursday bourse filing.This designation provides benefits for 707's development as a first-line treatment for PD-L1-positive locally advanced or metastatic non-small cell lung cancer, the filing stated.Drugs with that designation are entitled to policy support, prioritized communication resources, enhanced guidance, and accelerated development.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01530","BK1593","BK1583","BK1161"],"gpt_icon":0},{"id":"2528919794","title":"BRIEF-3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2528919794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528919794?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:29","pubTimestamp":1744885740,"startTime":"0","endTime":"0","summary":"BRIEF-3Sbio Says 707 Injection  Granted Breakthrough Therapy Designation By NMPAApril 17  - 3SBio Inc 1530.HK:707 INJECTION  GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPAFurther company coverage: 1530.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1161","BK1593","BK1583"],"gpt_icon":0},{"id":"2528769933","title":"3SBio -  707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2528769933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528769933?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:32","pubTimestamp":1744878747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01530","BK1593","BK1583","BK1161"],"gpt_icon":0},{"id":"2527288402","title":"BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527288402","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527288402?lang=en_us&edition=fundamental","pubTime":"2025-04-16 23:18","pubTimestamp":1744816681,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per ShareApril 16 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:REPURCHASED 10 MILLION SHARES AT AVERAGE PRICE OF HK$0.6274 PER SHAREFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1600","BK1515","BK1593","00460"],"gpt_icon":0},{"id":"2527962852","title":"Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527962852","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527962852?lang=en_us&edition=fundamental","pubTime":"2025-04-16 18:40","pubTimestamp":1744800030,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00460","BK1191","BK1515","BK1600","BK1593"],"gpt_icon":0},{"id":"2527137940","title":"Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137940","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137940?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:45","pubTimestamp":1744627530,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) (HKG:2196, SHA:600196) agreed to sell a total equity stake of 55% in Shanghai Fujian Equity Investment Fund Management to three parties for around 26.5 million yu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00656","BK0096","BK0187","BK0196","BK0175","600196","BK0012","BK1593","BK0183","BK0188","BK1515","BK1191","02196","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2527131746","title":"Corrected-Lai Fung Holdings H1 Turnover HKD 647.8 Million (Corrects Number)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527131746","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527131746?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:27","pubTimestamp":1744626470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL8N3QS0K2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01125","BK1240","BK1593"],"gpt_icon":0},{"id":"2527923216","title":"Angelalign Technology Inc. (HKG:6699) May Have Run Too Fast Too Soon With Recent 27% Price Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2527923216","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527923216?lang=en_us&edition=fundamental","pubTime":"2025-04-14 09:29","pubTimestamp":1744594171,"startTime":"0","endTime":"0","summary":"Angelalign Technology Inc. ( HKG:6699 ) shareholders won't be pleased to see that the share price has had a very rough...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-inc-hkg6699-may-have-run-too-fast-too","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FAST","06699","BK1593","BK4104","BK1100","BK4588","BK1587","IE00BFXG0V08.USD","BK1583","IE00B5TLWC47.USD","BK4567","BK4585","IE00BYQQ9H92.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}